1. Home
  2. IGC vs MODD Comparison

IGC vs MODD Comparison

Compare IGC & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IGC Pharma Inc.

IGC

IGC Pharma Inc.

HOLD

Current Price

$0.30

Market Cap

31.2M

Sector

Health Care

ML Signal

HOLD

Logo Modular Medical Inc.

MODD

Modular Medical Inc.

HOLD

Current Price

$0.40

Market Cap

33.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IGC
MODD
Founded
2005
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.2M
33.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IGC
MODD
Price
$0.30
$0.40
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$4.13
N/A
AVG Volume (30 Days)
936.3K
599.5K
Earning Date
02-17-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,106,000.00
N/A
Revenue This Year
$3.54
N/A
Revenue Next Year
$15.12
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.25
$0.28
52 Week High
$0.50
$1.49

Technical Indicators

Market Signals
Indicator
IGC
MODD
Relative Strength Index (RSI) 37.86 48.50
Support Level $0.29 $0.32
Resistance Level $0.31 $0.42
Average True Range (ATR) 0.03 0.05
MACD -0.00 0.01
Stochastic Oscillator 18.27 57.15

Price Performance

Historical Comparison
IGC
MODD

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

About MODD Modular Medical Inc.

Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.

Share on Social Networks: